294 related articles for article (PubMed ID: 25247382)
1. The patient burden of screening mammography recall.
Alcusky M; Philpotts L; Bonafede M; Clarke J; Skoufalos A
J Womens Health (Larchmt); 2014 Sep; 23 Suppl 1():S11-9. PubMed ID: 25247382
[TBL] [Abstract][Full Text] [Related]
2. Understanding patient options, utilization patterns, and burdens associated with breast cancer screening.
Harvey SC; Vegesna A; Mass S; Clarke J; Skoufalos A
J Womens Health (Larchmt); 2014 Sep; 23 Suppl 1():S3-9. PubMed ID: 25247383
[TBL] [Abstract][Full Text] [Related]
3. Performance goals for an adjunct diagnostic test to reduce unnecessary biopsies after screening mammography: analysis of costs, benefits, and consequences.
Lee CI; Bensink ME; Berry K; Musa Z; Bodnar C; Dann R; Jarvik JG; Lehman CD; Ramsey SD
J Am Coll Radiol; 2013 Dec; 10(12):924-30. PubMed ID: 24295942
[TBL] [Abstract][Full Text] [Related]
4. Performance Goals for an Adjunct Diagnostic Test to Reduce Unnecessary Biopsies After Screening Mammography: Analysis of Costs, Benefits, and Consequences.
Lee CI; Bensink ME; Berry K; Musa Z; Bodnar C; Dann R; Jarvik JG; Lehman CD; Ramsey SD
J Am Coll Radiol; 2016 Nov; 13(11S):R81-R88. PubMed ID: 27814820
[TBL] [Abstract][Full Text] [Related]
5. The impact of alternative practices on the cost and quality of mammographic screening in the United States.
Burnside E; Belkora J; Esserman L
Clin Breast Cancer; 2001 Jul; 2(2):145-52. PubMed ID: 11899786
[TBL] [Abstract][Full Text] [Related]
6. Comparison of screening mammography in the United States and the United kingdom.
Smith-Bindman R; Chu PW; Miglioretti DL; Sickles EA; Blanks R; Ballard-Barbash R; Bobo JK; Lee NC; Wallis MG; Patnick J; Kerlikowske K
JAMA; 2003 Oct; 290(16):2129-37. PubMed ID: 14570948
[TBL] [Abstract][Full Text] [Related]
7. Cost-effectiveness of mammography screening for breast cancer in a low socioeconomic group of Iranian women.
Barfar E; Rashidian A; Hosseini H; Nosratnejad S; Barooti E; Zendehdel K
Arch Iran Med; 2014 Apr; 17(4):241-5. PubMed ID: 24724599
[TBL] [Abstract][Full Text] [Related]
8. Minority report - false negative breast assessment in women recalled for suspicious screening mammography: imaging and pathological features, and associated delay in diagnosis.
Ciatto S; Houssami N; Ambrogetti D; Bonardi R; Collini G; Del Turco MR
Breast Cancer Res Treat; 2007 Sep; 105(1):37-43. PubMed ID: 17115112
[TBL] [Abstract][Full Text] [Related]
9. Outcome analysis for women undergoing annual versus biennial screening mammography: a review of 24,211 examinations.
Hunt KA; Rosen EL; Sickles EA
AJR Am J Roentgenol; 1999 Aug; 173(2):285-9. PubMed ID: 10430120
[TBL] [Abstract][Full Text] [Related]
10. National expenditure for false-positive mammograms and breast cancer overdiagnoses estimated at $4 billion a year.
Ong MS; Mandl KD
Health Aff (Millwood); 2015 Apr; 34(4):576-83. PubMed ID: 25847639
[TBL] [Abstract][Full Text] [Related]
11. Experiences of recall after mammography screening--a qualitative study.
Solbjør M; Forsmo S; Skolbekken JA; Sætnan AR
Health Care Women Int; 2011 Nov; 32(11):1009-27. PubMed ID: 21978146
[TBL] [Abstract][Full Text] [Related]
12. Can Medicare billing claims data be used to assess mammography utilization among women ages 65 and older?
Smith-Bindman R; Quale C; Chu PW; Rosenberg R; Kerlikowske K
Med Care; 2006 May; 44(5):463-70. PubMed ID: 16641665
[TBL] [Abstract][Full Text] [Related]
13. [Results of monitoring the year 2002 of the Hungarian breast cancer screening program].
Boncz I; Hoffer G; Sebestyén A; Dózsa C; Ember I
Magy Onkol; 2005; 49(2):109-15. PubMed ID: 16249805
[TBL] [Abstract][Full Text] [Related]
14. Mammography utilization, public health impact, and cost-effectiveness in the United States.
White E; Urban N; Taylor V
Annu Rev Public Health; 1993; 14():605-33. PubMed ID: 8323604
[No Abstract] [Full Text] [Related]
15. Screening Mammography Program of British Columbia: pattern of use and health care system costs.
Olivotto IA; Kan L; Mates D; King S
CMAJ; 1999 Feb; 160(3):337-41. PubMed ID: 10065075
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of an intervention to increase mammography screening in Los Angeles.
Bastani R; Marcus AC; Maxwell AE; Das IP; Yan KX
Prev Med; 1994 Jan; 23(1):83-90. PubMed ID: 8016038
[TBL] [Abstract][Full Text] [Related]
17. Trends in recall, biopsy, and positive biopsy rates for screening mammography in an academic practice.
Gur D; Wallace LP; Klym AH; Hardesty LA; Abrams GS; Shah R; Sumkin JH
Radiology; 2005 May; 235(2):396-401. PubMed ID: 15770039
[TBL] [Abstract][Full Text] [Related]
18. Benefits and costs of screening and treatment for early breast cancer. Development of a basic benefit package.
Kattlove H; Liberati A; Keeler E; Brook RH
JAMA; 1995 Jan; 273(2):142-8. PubMed ID: 7799495
[TBL] [Abstract][Full Text] [Related]
19. Women who are recalled for further investigation for breast screening: psychological consequences 3 years after recall and factors affecting re-attendance.
Brett J; Austoker J
J Public Health Med; 2001 Dec; 23(4):292-300. PubMed ID: 11873891
[TBL] [Abstract][Full Text] [Related]
20. Cumulative false positive recall rate and association with participant related factors in a population based breast cancer screening programme.
Castells X; Molins E; Macià F
J Epidemiol Community Health; 2006 Apr; 60(4):316-21. PubMed ID: 16537348
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
